EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Is There Still a Role for Autologous Stem Cell Transplantation in Older Adults with AML?

Saveria Capria iD, Clara Minotti, Massimo Breccia iD, Maria Laura Bisegna, Ida Carmosino, Patrizia Chiusolo iD, Luca Di Marino iD, Giovanni Luzi iD, Sabrina Mariani iD, Giovanni Marsili, Leonardo Marabitti iD, Elettra Ortu La Barbera und 3 weitere

Hematology Reports · 12.08.2026 · 18 (4) · 57

DOI: 10.3390/hematolrep18040057 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Hematology Reports, online erschienen am 12.08.2026. Verfasst von Saveria Capria und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hematology, AOU Policlinico Umberto I-Sapienza University, 00161 Rome, Italy. Die Arbeit nennt 20 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Autologous stem cell transplantation (ASCT) is regaining interest as a consolidation strategy for acute myeloid leukemia (AML) patients with favorable/intermediate risk and measurable residual disease (MRD) negativity. In fit older adults, its role remains debated due to concerns regarding toxicity and stem cell collection.

Aim

To evaluate the long-term outcomes of ASCT in AML patients aged ≥60 years in first complete remission (CR1).

Methods

We retrospectively analyzed 43 non-M3 AML patients (median age 64, range 60–72) who underwent ASCT in CR1 across five centers (2000–2024). Risk was stratified by ELN 2017. Primary endpoints were overall survival (OS) and disease-free survival (DFS).

Results

The cohort included 22 favorable-risk and 21 intermediate-risk patients. Most (88%) achieved CR1 after one induction course. Median neutrophil and platelet engraftment occurred at 13 and 15 days, respectively. Grade III/IV infections were observed in 28% of patients; transplant-related mortality was low at 4%. At a median follow-up of 77 months, 5-year OS and DFS were 51% (95% CI: 37–70%) and 47% (95% CI: 34–65%), respectively. OS was significantly superior in favorable- versus intermediate-risk patients (68% vs. 35%, p = 0.027), with a similar trend for DFS (57% vs. 35%, p = 0.07). The number of consolidation cycles did not impact survival outcomes.

Conclusions

This multicenter study confirms that ASCT is a feasible and effective consolidation strategy for selected fit AML patients aged ≥60. The low mortality and encouraging survival, particularly in favorable-risk subgroups, support ASCT as a valid alternative to prolonged chemotherapy or maintenance.

Schlagwörter

Stichwörter der Autor:innen

acute myeloid leukemiaautologous stem cell transplantationelderly

Autor:innen und Institutionen

  • Department of Hematology, AOU Policlinico Umberto I-Sapienza University, 00161 Rome, Italy.
  • Hematology, Department of Translational and Precision Medicine, Sapienza University, 00161 Rome, Italy.
  • Ematologia e Trapianto, Dipartimento di Scienze Ematologiche e di Laboratorio, Fondazione Policlinico Universitario A. Gemelli IRCCS, Sezione di Ematologia, Università Cattolica del Sacro Cuore, 00168 Rome, Italy.
  • UOC Ematologia e Trapianto di Cellule Staminali, San Camillo-Forlanini Hospital, 00152 Rome, Italy.
  • Hematology Unit, AOU Sant'Andrea, Sapienza University, 00189 Rome, Italy.
  • GIMEMA Foundation, 00182 Rome, Italy.

ORCID-Profile: Saveria Capria, Massimo Breccia, Patrizia Chiusolo, Luca Di Marino, Giovanni Luzi, Sabrina Mariani, Leonardo Marabitti

Zitieren

APA

Capria, S., Minotti, C., Breccia, M., Bisegna, M. L., Carmosino, I., Chiusolo, P., Di Marino, L., Luzi, G., Mariani, S., Marsili, G., Marabitti, L., Ortu La Barbera, E., Scollo, L., Martelli, M., & Trisolini, S. M. (2026). Is There Still a Role for Autologous Stem Cell Transplantation in Older Adults with AML?. Hematology Reports, 18(4), 57. https://doi.org/10.3390/hematolrep18040057

Vancouver

Capria S, Minotti C, Breccia M, Bisegna ML, Carmosino I, Chiusolo P, et al. Is There Still a Role for Autologous Stem Cell Transplantation in Older Adults with AML?. Hematology Reports. 2026;18(4):57. doi:10.3390/hematolrep18040057

BibTeX
@article{Capria2026,
  author = {Capria, Saveria and Minotti, Clara and Breccia, Massimo and Bisegna, Maria Laura and Carmosino, Ida and Chiusolo, Patrizia and Di Marino, Luca and Luzi, Giovanni and Mariani, Sabrina and Marsili, Giovanni and Marabitti, Leonardo and Ortu La Barbera, Elettra and Scollo, Lorena and Martelli, Maurizio and Trisolini, Silvia Maria},
  title = {Is There Still a Role for Autologous Stem Cell Transplantation in Older Adults with AML?},
  journal = {Hematology Reports},
  year = {2026},
  volume = {18},
  number = {4},
  pages = {57},
  doi = {10.3390/hematolrep18040057}
}
Kostenlos starten →